Natural Alternatives International Inc is formulator, manufacturer and marketer of nutritional supplements. Its comprehensive strategic partnerships with its customers allow to offer a wide range of nutritional products and services to such customers including scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review, and international product registration assistance. It has two segments Private-label contract manufacturing, and Patent and trademark licensing. Majority of revenue comes from Private-label contract manufacturing. Majority of revenue comes from United States.
Last trade$0.00
Day change$0.00 (0.00%)
Day range$0.955 – $1.01
Volume813
Market cap$6M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$6.07M
Price / earnings
—
Price / book
0.12×
Price / sales
0.04×
EV / sales
0.12×
EV / EBITDA
-4.63×
Profitability
Earnings per share
-$3.31
Return on assets
-16.37%
Return on equity
-41.42%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0.36×
Current ratio
1.73×
Quick ratio
0.92×
Cash ratio
0.2×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$12.62M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for NAII, quarterly periods
Line item
Q4 FY2026 Jun 30, 2026
Q3 FY2026 Mar 31, 2026
Q2 FY2026 Dec 31, 2025
Q1 FY2026 Sep 30, 2025
Q4 FY2025 Jun 30, 2025
Q3 FY2025 Mar 31, 2025
Q2 FY2025 Dec 31, 2024
Q1 FY2025 Sep 30, 2024
Revenue
$34.51M
$35.48M
$34.8M
$37.73M
$33.87M
$28.77M
$34.08M
$33.15M
Cost of revenue
$32.78M
$35.1M
$32.3M
$33.33M
$30.33M
$26.94M
$32.41M
$30.89M
Gross profit
$1.73M
$383K
$2.49M
$4.4M
$3.54M
$1.83M
$1.67M
$2.26M
Selling, general and administrative
$4.45M
$4.4M
$4.34M
$4.11M
$4.08M
$3.93M
$4.45M
$4.1M
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$14.9M
$4.4M
$4.34M
$4.11M
$5.48M
$3.93M
$4.45M
$4.1M
Operating income
-$13.18M
-$4.01M
-$1.85M
$284K
-$1.94M
-$2.1M
-$2.78M
-$1.84M
Interest expense
-$466K
-$270K
-$224K
-$226K
-$212K
-$246K
-$278K
-$178K
Income before taxes
-$13.49M
-$4.24M
-$2.33M
-$199K
-$2.82M
-$2.64M
-$2.87M
-$2.41M
Income taxes
$46K
$68K
$224K
$92K
$4.4M
-$456K
-$675K
-$431K
Net income
-$13.54M
-$4.31M
-$2.55M
-$291K
-$7.22M
-$2.19M
-$2.19M
-$1.98M
Net income attributable to common shareholders
-$13.54M
-$4.31M
-$2.55M
-$291K
-$7.22M
-$2.19M
-$2.19M
-$1.98M
EBITDA
-$1.54M
-$2.82M
-$681K
$1.45M
$616K
-$961K
-$1.65M
-$709K
Basic earnings per share
-$2.23
-$0.72
-$0.42
-$0.05
-$1.20
-$0.37
-$0.37
-$0.33
Diluted earnings per share
-$2.23
-$0.72
-$0.42
-$0.05
-$1.20
-$0.37
-$0.37
-$0.33
Recent news
Company coverage with links to the original publishers.
Natural Alternatives International (NAII) reported Q4 FY2026 net sales of $34.5 million (up 1.9% YoY) but posted a net loss of $13.5 million, including a $10.4 million impairment charge on its Carlsbad facility. The company is consolidating U.S. manufacturing operations into its Vista facility and exploring strategic alternatives including potential sale, merger, or acquisition to improve profitability and shareholder value.
CarnoSyn® Brands and parent company Natural Alternatives International, Inc. (NAI) have announced a new distribution partnership with B&D Nutritional Ingredients, Inc. to distribute NAI's new carnosine booster, TriBsyn™, in the U.S. dietary supplement, functional food, and beverage market.
Natural Alternatives International, Inc. reported a net loss of $1.9 million for the fourth quarter of fiscal year 2024, compared to a net income of $2.0 million in the prior year period. The company's net sales decreased by 18% during the quarter, primarily due to reduced orders from one of its larger customers.
Natural Alternatives International, Inc. (NAI) and CarnoSyn® Brands will exhibit at the ESPEN Congress on Clinical Nutrition & Metabolism in Milan, Italy, showcasing their new product TriBsyn™, a patent-pending formula that increases beta-alanine bioavailability and absorption.
CARLSBAD, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $1.6 million, or ($0.27) per diluted share, on net sales of $25.1 million for the third quarter of fiscal year 2024 compared to a net loss of $2.4 million, or ($0.41) per diluted share, in the third quarter of the prior fiscal year.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.